Hydroxychloroquine: Brazil maintains drug advice despite WHO warning

0
749
Hydroxychloroquine: Brazil maintains drug advice despite WHO warning











Published on May 26, 2020

Brazil has said it won’t change its recommendation to use a malaria drug to fight coronavirus, even though the World Health Organization has suspended trials of hydroxychloroquine because of safety concerns

Brazil has the second highest number of coronavirus infections (374,898) and the sixth highest number of deaths (23,473) in the world, a tally by Johns Hopkins University shows.

Please subscribe HERE http://bit.ly/1rbfUog

Testing of the malaria drug hydroxychloroquine as a possible treatment for coronavirus has been halted because of safety fears, the World Health Organization (WHO) says.

Trials in several countries are being “temporarily” suspended as a precaution, the agency said on Monday.

It comes after a recent medical study suggested the drug could increase the risk of patients dying from Covid-19.

President Donald Trump has said he has taken the drug to ward off the virus.

The US president has repeatedly promoted the anti-malarial drug, against medical advice and despite warnings from public health officials that it could cause heart problems.

Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here